← Leaderboards
Kristin R. Harrington
Emory University
$206,002
Attributed
$206,002
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2020–23$100K$75K$50K$25K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$206,002 · 1
By mechanism
F30$206,002 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Henry M Blumberg$34,304,291
- Jyothi Rengarajan$20,334,619
- Russell Ryan Kempker$3,115,410
- Cassandra D Josephson$6,289,579
- Patrick Sean Sullivan$49,786,126
Others in their field
Other Emerging Leaders on “Bayesian Method”
- Charles C Miller · University Of Texas Hlth Sci Ctr Houston$5,838,851
- Walter K. Kremers · Mayo Clinic Rochester$4,257,972
- Veronique Belzil · Massachusetts Institute Of Technology$4,105,202
- Yize Zhao · Yale University$4,000,825
- Steve Presse · Arizona State University-Tempe Campus$3,786,167
- Juan Eugenio Iglesias Gonzalez · Massachusetts General Hospital$3,730,389
Research focus
Bayesian MethodBayesian ModelingBeautyBiometryCarbon DioxideCategoriesCensusesCessation Of LifeChurchClinicCohort StudiesCommunicable DiseasesCommunitiesCountryData CollectionDependenceDiagnosisDoseDrug ResistanceDrug Resistance In TuberculosisEpidemicEpidemiologic MethodsEpidemiologyArea
Grant awards (4)
Investigating Transmission Risk and Incidence of Extensively Drug-Resistant Tuberculosis in South Africa$52,694
F30 · FY2023 · AI · contact PI
Investigating Transmission Risk and Incidence of Extensively Drug-Resistant Tuberculosis in South Africa$51,752
F30 · FY2022 · AI · contact PI
Investigating Transmission Risk and Incidence of Extensively Drug-Resistant Tuberculosis in South Africa$51,036
F30 · FY2021 · AI · contact PI
Investigating Transmission Risk and Incidence of Extensively Drug-Resistant Tuberculosis in South Africa$50,520
F30 · FY2020 · AI · contact PI